Product Information
- N1,N3,N5-Tris(2-hydroxyethyl)-1,3,5-benzenetricarboxamide
- LM 22A4
- N,N′,N′′-Tris(β-hydroxyethyl)trimesamide
- 1,3,5-Benzenetricarboxamide, N,N′,N′′-tris(2-hydroxyethyl)-
- 1,3,5-Benzenetricarboxamide, N1,N3,N5-tris(2-hydroxyethyl)-
LM22A-4 is a monoclonal antibody that binds to the neurotrophic factor nerve growth factor (NGF) and prevents it from activating its receptor. LM22A-4 has been shown to have neuroprotective effects in vivo, and can be used to treat neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Additionally, LM22A-4 has been shown to promote neuronal function by increasing energy metabolism and mitochondrial biogenesis in vitro. The molecule also has immunomodulatory properties that may help with inflammatory conditions such as arthritis or asthma.
LM22A-4 is an antibody that was generated from a mouse immunized with human NGF. It binds to the natural compound NGF and prevents it from activating its receptor. LM22A-4 has been shown to have neuroprotective effects in vivo, and can be used to treat neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and
Chemical properties
Technical inquiry about: 3D-MBA98818 LM22A-4
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
